Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 47 clinical trials
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

The primary objective of this study is to measure the concentration and the regional brain distribution of activated brain microglia/macrophages using the PET radiopharmaceutical [F-18]DPA-714

chronic pain
fibromyalgia
disease or disorder
radiopharmaceutical
fatigue
  • 554 views
  • 22 Sep, 2021
  • 1 location
Pilot Study Evaluating Somatostatin Receptor's PET Imaging to Detect Inflammatory Phases of Myocarditis

. However, anomalies observed in MRI are not specific and it is necessary to use multiple criterions. A new radiopharmaceutical, the 68Ga-DOTATOC, specific of somatostatin's receptors which are over

MRI
angiography
cardiac mri
heart disease
  • 0 views
  • 17 Aug, 2021
  • 1 location
Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors (Phase 2)

(and per cycle) activities radiopharmaceutical and according to the concept of dose hyperfractionation - with a view to an optimal balance between risk and benefit.

  • 1 views
  • 18 Mar, 2021
  • 1 location
Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma

radiopharmaceutical unit, before the first cycle of clinically scheduled immunotherapy. Scintigraphy images will be acquired dynamically from time of injection to +30 minutes. Quantitative SPECT/CT (xSPECT/CT

advanced melanoma
metastatic melanoma
  • 0 views
  • 12 Aug, 2021
  • 1 location
Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC

major cause of death, disability, and decreased quality of life. Radium-223 is radiopharmaceutical meaning that the drug is a radioactive compound used for therapeutic purposes. It is given

bone scan
orchiectomy
abiraterone
androgen ablation
neutrophil count
  • 33 views
  • 26 Apr, 2021
  • 1 location
68Ga-NODAGA-RGD PET in Patients With an Occluded Coronary Artery

radiopharmaceutical for positron emission tomography (PET) imaging of V3 integrin expression. Aim: This study aims at evaluating the feasibility of imaging myocardial V3 integrin expression using 68-Ga-NODAGA

  • 0 views
  • 09 May, 2021
  • 3 locations
Detection of Integrin avb6 in IPF PSC and COVID19 Using PET/CT

Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 with [18F]FP-R01-MG-F2 with PET/CT

idiopathic pulmonary fibrosis
fibrosis
pneumonia
  • 93 views
  • 24 Mar, 2021
  • 1 location
18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer

This is an interventional, single group assignment, prospective nonrandomized, open label Phase 2 trial designed to evaluate 18F-DCFPyL PET imaging in men diagnosed with prostate cancer with increasing prostate-specific antigen (PSA) levels.

  • 0 views
  • 31 May, 2021
  • 1 location
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis

To demonstrate feasibility of imaging Cu[64]-25%-CANF-Comb uptake in the atherosclerosis of the carotid artery of patients for whom carotid artery endarterectomy surgery is planned in comparison to the carotid artery for which intervention is not planned.

endarterectomy
atherosclerosis
positron emission tomography
natriuretic peptide
  • 35 views
  • 21 Jun, 2021
  • 1 location
Study of MIBG-I131 in Patients With Well Differentiated Neuroendocrine Tumors

This is a single-arm, unicentric, single-stage, phase 2 clinical study of therapeutic metaiodobenzylguanidine (MIBG) for patients with metastatic well-differentiated neuroendocrine tumors and radiological progression or intolerance after standard lines of treatment and with MIBG positive scan.

  • 0 views
  • 13 Apr, 2021
  • 1 location